Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2016 - 2025)

Kazia Therapeutics has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $178345.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 85.51% year-over-year to $178345.0; the trailing twelve-month figure through Dec 2025 stood at $178345.0 (down 85.51% YoY), and the FY2025 full-year result was $173960.2, down 86.92% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2025 stood at $178345.0, up from $173960.2 in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $2.3 million in Q2 2021, with the low at $173960.2 in Q2 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• Annual changes were most pronounced in 2021 — Non-Current Deferred Tax Liability climbed 0.79% — and 2025, when it sank 86.92%.
• Kazia Therapeutics' Non-Current Deferred Tax Liability stood at $2.1 million in 2021, then declined by 21.15% to $1.7 million in 2022, then fell by 21.9% to $1.3 million in 2023, then decreased by 6.29% to $1.2 million in 2024, then sank by 85.51% to $178345.0 in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $178345.0 (Q4 2025), $173960.2 (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.